AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+2.75%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.17B
AUM Growth
+$2.17B
(+3.9%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
7.14%
Top 10 Holdings %
Top 10 Hldgs %
58.3%
Holding
120
New
20
Increased
21
Reduced
32
Closed
19
Top Buys
| 1 |
Avantor
AVTR
|
$134M |
| 2 |
Zillow
Z
|
$41.8M |
| 3 |
Uber
UBER
|
$23.2M |
| 4 |
Cyclerion Therapeutics
CYCN
|
$15.6M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$11M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$48.8M |
| 2 |
InflaRx
IFRX
|
$31.2M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$11M |
| 4 |
Wave Life Sciences
WVE
|
$9.71M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$9.43M |
Sector Composition
| 1 | Healthcare | 72.1% |
| 2 | Consumer Discretionary | 17.9% |
| 3 | Technology | 5.46% |
| 4 | Communication Services | 2.13% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
FibroGen
FGEN
$47.8M
| $8.13M | 0.33% | 180,000 -20,000 | -10% | -$904K |
|
|
AUTL
52
Autolus Therapeutics
AUTL
$399M
| $8.05M | 0.33% | 500,000 +50,000 | +11% | +$805K |
|
53
TG Therapeutics
TGTX
$4.65B
| $7.79M | 0.31% | 900,000 +100,000 | +13% | +$865K |
|
|
ARQL
54
DELISTED
Arqule Inc
ARQL
| $7.71M | 0.31% | +700,000 | New | +$7.71M |
|
|
HOOK
55
DELISTED
HOOKIPA Pharma
HOOK
| $7.64M | 0.31% | +1,134,616 | New | +$7.64M |
|
|
AGEN
56
Agenus
AGEN
$133M
| $7.5M | 0.3% | 2,500,000 -250,000 | -9% | -$750K |
|
57
Regenxbio
RGNX
$451M
| $7.45M | 0.3% | 145,000 -25,000 | -15% | -$1.28M |
|
|
TCRR
58
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $7.01M | 0.28% | 490,000 | – | – |
|
59
Solid Biosciences
SLDB
$427M
| $6.9M | 0.28% | 1,200,000 | – | – |
|
60
CrowdStrike
CRWD
$106B
| $6.83M | 0.28% | +100,000 | New | +$6.83M |
|
61
Spero Therapeutics
SPRO
$116M
| $6.22M | 0.25% | 540,000 -60,000 | -10% | -$691K |
|
|
GRTS
62
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $5.57M | 0.23% | 500,000 +300,000 | +150% | +$3.34M |
|
63
AC Immune
ACIU
$205M
| $5.55M | 0.22% | 1,000,000 | – | – |
|
|
STML
64
DELISTED
Stemline Therapeutics, Inc.
STML
| $5.52M | 0.22% | 360,000 -40,000 | -10% | -$613K |
|
65
Rocket Pharmaceuticals
RCKT
$354M
| $5.4M | 0.22% | 360,000 -40,000 | -10% | -$600K |
|
66
BridgeBio Pharma
BBIO
$9.89B
| $5.39M | 0.22% | +200,000 | New | +$5.39M |
|
67
Allogene Therapeutics
ALLO
$251M
| $5.37M | 0.22% | 200,000 -200,000 | -50% | -$5.37M |
|
68
Merus
MRUS
$4.98B
| $5.13M | 0.21% | 350,000 +50,000 | +17% | +$733K |
|
|
ORTX
69
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $4.9M | 0.2% | +350,000 | New | +$4.9M |
|
70
CRISPR Therapeutics
CRSP
$4.71B
| $4.71M | 0.19% | 100,000 -45,000 | -31% | -$2.12M |
|
71
Sangamo Therapeutics
SGMO
$157M
| $4.36M | 0.18% | 405,000 +5,000 | +1% | +$53.9K |
|
72
Frontdoor
FTDR
$4.43B
| $4.36M | 0.18% | +100,000 | New | +$4.36M |
|
73
Alector
ALEC
$238M
| $4.28M | 0.17% | 225,000 -25,000 | -10% | -$475K |
|
74
Cartesian Therapeutics
RNAC
$261M
| $3.76M | 0.15% | 2,100,000 | – | – |
|
75
Adicet Bio
ACET
$59.9M
| $3.67M | 0.15% | 360,000 -40,000 | -10% | -$408K |
|